Showing results (51-60 of 120) with videos related to
Sort By:
Pageof 12
Clinical Child and Family Psychology Review|November 21, 2025
The Use of Social Robots in Primary School to Support Children's Academic and Social Emotional Learning: A Scoping ReviewRuby-Jane Barry, Michelle M Neumann, Bonnie A Clough, et al.Journal of Wildlife Diseases|April 29, 2015
Trichomonas gallinae Persistence in Four Water TreatmentsKathryn E Purple, Jacob M Humm, R Brian Kirby, et al.Dermatology (Basel, Switzerland)|March 20, 2025
Time to Loss of Disease Control following Guselkumab Withdrawal in Relation to Initial Speed of Response: A post hoc Analysis of the VOYAGE 2 TrialBrian Kirby, Andrea Chiricozzi, Patricia Gorecki, et al.International Journal of Epidemiology|August 10, 2022
Comparison of intergenerational instrumental variable analyses of body mass index and mortality in UK BiobankCiarrah-Jane Barry, David Carslake, Kaitlin H Wade, et al.Biomicrofluidics|December 20, 2016
Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMTTimothy Lannin, Wey-Wey Su, Conor Gruber, et al.Dermatology (Basel, Switzerland)|April 10, 2025
Treatment of Plaque Psoriasis with Guselkumab Reduces Systemic Inflammatory Burden as Measured by Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Monocyte/Lymphocyte Ratio: A post hoc Analysis of Three Randomised Clinical TrialsNiamh Kearney, Patricia Gorecki, Lorenzo Acciarri, et al.Arthritis and Rheumatism|October 19, 2011
HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotypeRobert Winchester, Gregory Minevich, Valeria Steshenko, et al.International Journal of Dermatology|August 2, 2017
Adipokines, psoriasis, systemic inflammation, and endothelial dysfunctionMaeve Lynch, Tomas Ahern, Cheryl M Sweeney, et al.Acta Dermato-Venereologica|September 5, 2024
Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE TrialEnzo Errichetti, Peter Wolf, Saakshi Khattri, et al.The Journal of Rheumatology|May 18, 2010
Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritisAnne-Marie Tobin, Douglas J Veale, Oliver Fitzgerald, et al.Pageof 12